Assessing outcomes for freezing of gait in Parkinson's disease
Official title: An International Multimodal Protocol for Assessing Freezing of Gait in Individuals Living with Parkinson's Disease
Run by Tel-Aviv Sourasky Medical Center · NCT06519279 · Data updated 2026-11-12
This study is trying to find better ways to measure how bad freezing of gait is for people with Parkinson's disease who can walk on their own.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Tel-Aviv Sourasky Medical Center Government |
| Locations | 1 site (Tel Aviv) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | January 28, 2025 |
| Trial ID | NCT06519279 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with idiopathic Parkinson's disease who experience freezing of gait and can walk independently.
✕Probably not a fit
Patients who have recently experienced significant cardiovascular events or have unstable medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop reliable clinician-reported and patient-reported outcome measures to quantify the severity of freezing of gait (FOG) in patients with Parkinson's disease. It will involve patients diagnosed with idiopathic Parkinson's disease who can walk independently and have stable treatment. The study will utilize specific interventions to gather data on FOG severity, which will help in creating standardized assessment tools for clinicians and researchers.
Why it matters
Potential benefit: If successful, this study could provide a standardized method for assessing freezing of gait, leading to improved management and treatment strategies for patients with Parkinson's disease.
How similar studies have gone: Other studies have shown success in developing outcome measures for Parkinson's disease, indicating that this approach has potential for meaningful advancements.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of idiopathic Parkinson's disease (PD) made by a neurologist according to the Movement Disorders Society guidelines; 2. Able to walk independently for a distance of 10 meters, without walking aid; 3. Absence of a Deep Brain Stimulator; 4. Stable PD treatment in the 4 weeks prior to participation that is not expected to change in the course of the study. 5. For patients with FOG: a score of ≥ 1 on the New Freezing Of Gait Questionnaire (NFOG-Q). Exclusion Criteria: 1. Occurrence of any of the following within 3 months prior to informed consent: myocardial infarction, hospitalization for unstable angina, stroke, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), implantation of a cardiac resynchronization therapy device (CRTD), active treatment for cancer or other malignant disease, uncontrolled congestive heart disease (NYHA class \>3), acute psychosis or major psychiatric disorders or continued substance abuse, other neurological (than PD) or orthopaedic impairment that significantly impacts on gait. 2. Unwilling to temporarily delay the morning anti-Parkinsonian medication. 3. Preganacy and
Where it's running
-
Tel Aviv Saurasky Medical Center
Tel Aviv, Israel Recruiting
Study contacts
- Study coordinator: Omri Batori, B.sc
- Email: omrib@tlvmc.gov.il
- Phone: +972546670256
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adaptive daytime DBS parameter optimization for people with Parkinson's disease
This study tests if aMedtronic Percept adaptive DBS can dynamically adjust stimulation in people with Parkinson's who already have DBS hardware.
-
Simplified, scalable 24-hour adaptive deep brain stimulation for Parkinson's disease
This study will test whether a less invasive under‑scalp recording system can drive around‑the‑clock adaptive deep brain stimulation to help people with Parkinson's disease who have motor fluctuations or sleep problems.
-
Transplanting stem cells to treat Parkinson's disease
This study is testing whether transplanting special stem cells into the brains of people with Parkinson's disease can help improve their symptoms and overall health.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Brain alpha-synuclein PET imaging in Parkinson's patients and healthy seniors
This open-label study tests a radioactive tracer called [18F]MK-0947 to see how it behaves in the brains of people with Parkinson's disease compared with healthy elderly volunteers.
-
Parkinson’s self-sufficiency and rehabilitation in a Czech spa setting
This intervention tests whether a Czech self-sufficiency test can be used with people with Parkinson’s disease and sees how spa-based rehabilitation affects independence, cognition, balance, and walking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.